NASDAQ
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.
Open
$2.70
Previous Close
$2.74
Day High
$3.13
Day Low
$2.69
52 Week High
$28.50
52 Week Low
$2.50
No price data available for this timeframe.